Sergio Antonio Barahona-Botache
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sergio Antonio Barahona-Botache has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
Alexis Agustin Dunay Silva
1 shared publication- Daniel Gilberto González Santos
Universidad de Pamplona
1 shared publication - Danna Lianeth Vásquez-Castañeda
School of Medicine, Universidad Tecnológica de Pereira, Pereira, Colombia
1 shared publication Departamento de Cirugía Plástica. Buenos Aires Universidad de Buenos Aires
1 shared publicationDepartamento de Medicina. Barranquilla Universidad Libre
1 shared publicationDepartamento de Medicina. Montería Universidad del Sinú
1 shared publication
Latest Publications
- Open Access
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Complete Mesocolic Excision With Central Vascular Ligation Versus Standard Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis of Lymph-Node Harvest (Preprint)
BACKGROUND Complete mesocolic excision (CME) with central vascular ligation has been proposed to improve lymph-node harvest compared with standard colectomy for colon cancer, though prior reviews report inconsistent heterogeneity and safety findings. OBJECTIVE This review aims to comprehensively synthesize lymph-node harvest as the primary outcome across the most current available evidence comparing CME with standard colectomy. METHODS PubMed, Cochrane CENTRAL, and ScienceDirect were searched to August 2026 per PRISMA 2020 guidelines. Risk of bias was assessed using RoB 2 and ROBINS-I; certainty was rated using GRADE. Continuous outcomes were pooled as mean differences and dichotomous outcomes as risk ratios using random-effects models in Review Manager (RevMan), with heterogeneity assessed via I² and Tau². Studies reporting outcomes in incompatible formats were synthesized narratively alongside pooled estimates. RESULTS Eighteen studies were included. For lymph-node yield, eight studies (n=926 CME, 1,145 comparator) pooled as mean differences showed CME significantly increased yield (MD 6.62, 95% CI [4.40, 8.84]; I²=80%), reduced after confounder-based subgrouping (confound-free MD 8.78, I²=61%; confounded MD 4.14, I²=58%; p=.010); narratively, all remaining studies reporting yield as medians, graded exposure, or unpooled means also favoured CME without exception. For the ≥12-node threshold, four studies showed no overall difference (RR 1.07, 95% CI [0.95, 1.21]; I²=81%), becoming significant after excluding one outlying study (RR 1.13, 95% CI [1.02, 1.24]; I²=51%); two additional studies reported this narratively, one non-significant and one showing the largest individual effect (94.7% vs. 79.1%, p<.001). Node positivity showed no pooled difference across thirteen studies (RR 0.99, 95% CI [0.87, 1.13]; I²=47%), while narratively synthesized studies showed mixed, largely non-significant findings. Postoperative complications showed no difference across eight pooled studies (RR 1.00, 95% CI [0.88, 1.13]; I²=0%), corroborated narratively across nine further studies with only one exception showing higher non-severe morbidity. CONCLUSIONS CME consistently increases lymph-node harvest without increasing perioperative complications, though evidence certainty remains low-to-moderate and long-term oncological benefit is unconfirmed.
- 3 November 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessComplete Mesocolic Excision With Central Vascular Ligation Versus Standard Colectomy for Colon Cancer: A Systematic Review and Meta-Analysis of Lymph-Node Harvest (Preprint)
BACKGROUND Complete mesocolic excision (CME) with central vascular ligation has been proposed to improve lymph-node harvest compared with standard colectomy for colon cancer, though prior reviews report inconsistent heterogeneity and safety findings. OBJECTIVE This review aims to comprehensively synthesize lymph-node harvest as the primary outcome across the most current available evidence comparing CME with standard colectomy. METHODS PubMed, Cochrane CENTRAL, and ScienceDirect were searched to August 2026 per PRISMA 2020 guidelines. Risk of bias was assessed using RoB 2 and ROBINS-I; certainty was rated using GRADE. Continuous outcomes were pooled as mean differences and dichotomous outcomes as risk ratios using random-effects models in Review Manager (RevMan), with heterogeneity assessed via I² and Tau². Studies reporting outcomes in incompatible formats were synthesized narratively alongside pooled estimates. RESULTS Eighteen studies were included. For lymph-node yield, eight studies (n=926 CME, 1,145 comparator) pooled as mean differences showed CME significantly increased yield (MD 6.62, 95% CI [4.40, 8.84]; I²=80%), reduced after confounder-based subgrouping (confound-free MD 8.78, I²=61%; confounded MD 4.14, I²=58%; p=.010); narratively, all remaining studies reporting yield as medians, graded exposure, or unpooled means also favoured CME without exception. For the ≥12-node threshold, four studies showed no overall difference (RR 1.07, 95% CI [0.95, 1.21]; I²=81%), becoming significant after excluding one outlying study (RR 1.13, 95% CI [1.02, 1.24]; I²=51%); two additional studies reported this narratively, one non-significant and one showing the largest individual effect (94.7% vs. 79.1%, p<.001). Node positivity showed no pooled difference across thirteen studies (RR 0.99, 95% CI [0.87, 1.13]; I²=47%), while narratively synthesized studies showed mixed, largely non-significant findings. Postoperative complications showed no difference across eight pooled studies (RR 1.00, 95% CI [0.88, 1.13]; I²=0%), corroborated narratively across nine further studies with only one exception showing higher non-severe morbidity. CONCLUSIONS CME consistently increases lymph-node harvest without increasing perioperative complications, though evidence certainty remains low-to-moderate and long-term oncological benefit is unconfirmed.
- Open Access
- 17 September 2024
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 24 (3) , e2811
Investigación científica suramericana sobre el uso de toxina botulínica en cirugía plástica: análisis bibliométrico sobre artículos indexados en Scopus
Objetivo: Analizar la evolución científica del uso de la toxina botulínica en cirugía plástica en América Latina. Materiales y métodos: Se realizó un estudio bibliométrico transversal utilizando Scopus como fuente de datos. Se ejecutó un análisis visual y bibliométrico, y se generaron cálculos métricos para evaluar la evolución, características generales e impacto de la evidencia latinoamericana sobre el uso de la toxina botulínica en cirugía plástica. Para este análisis se utilizó el paquete bibliometrix en R. Resultados: Se incluyeron 34 documentos publicados entre 2002 y 2023. El 70,5 % (n = 24) fueron artículos originales y el 23,5 %, revisiones (n = 8). Se identificó una colaboración internacional del 32,3 %. Los cuatro autores más prolíficos procedían de Colombia y Brasil, quienes publicaron únicamente dos documentos cada uno. Brasil (n = 20) es el país más prolífico, seguido de Chile (n = 5), Argentina (n = 4) y Colombia (n = 4). En cuanto a las tendencias de investigación, se encontró que la calidad de vida, los rellenos dérmicos, el ácido hialurónico y las arrugas son los subtemas más relacionados con el uso de la toxina botulínica en cirugía plástica en América Latina. Básicamente, hay cinco nichos de líneas de investigación asociadas, relacionados con síntomas y procedimientos estéticos, complicaciones cosméticas y calidad de vida. El grado de desarrollo de los temas depende esencialmente de las intervenciones estéticas. El análisis de correspondencia múltiple basado en las palabras clave de los autores reveló que el seguimiento de pacientes, el estudio de cohortes, la evaluación de riesgos, la evaluación de resultados, el rejuvenecimiento y los adultos son los elementos que complementan principalmente los subtemas de base. Conclusiones: Se ha identificado un crecimiento lento con una producción e impacto bajos en los últimos 20 años de investigación latinoamericana sobre el uso de la toxina botulínica en cirugía plástica. La investigación se ha centrado en estudios clínicos relacionados con la evaluación de resultados clínicos, calidad de vida y técnicas estéticas. Brasil lidera la investigación en la región y mantiene una fuerte red de colaboración intercontinental.
- 17 September 2024
- Published by Universidad de San Martin de Porres in Horizonte Médico (Lima)
- Vol. 24 (3) , e2811
Open AccessInvestigación científica suramericana sobre el uso de toxina botulínica en cirugía plástica: análisis bibliométrico sobre artículos indexados en Scopus
Objetivo: Analizar la evolución científica del uso de la toxina botulínica en cirugía plástica en América Latina. Materiales y métodos: Se realizó un estudio bibliométrico transversal utilizando Scopus como fuente de datos. Se ejecutó un análisis visual y bibliométrico, y se generaron cálculos métricos para evaluar la evolución, características generales e impacto de la evidencia latinoamericana sobre el uso de la toxina botulínica en cirugía plástica. Para este análisis se utilizó el paquete bibliometrix en R. Resultados: Se incluyeron 34 documentos publicados entre 2002 y 2023. El 70,5 % (n = 24) fueron artículos originales y el 23,5 %, revisiones (n = 8). Se identificó una colaboración internacional del 32,3 %. Los cuatro autores más prolíficos procedían de Colombia y Brasil, quienes publicaron únicamente dos documentos cada uno. Brasil (n = 20) es el país más prolífico, seguido de Chile (n = 5), Argentina (n = 4) y Colombia (n = 4). En cuanto a las tendencias de investigación, se encontró que la calidad de vida, los rellenos dérmicos, el ácido hialurónico y las arrugas son los subtemas más relacionados con el uso de la toxina botulínica en cirugía plástica en América Latina. Básicamente, hay cinco nichos de líneas de investigación asociadas, relacionados con síntomas y procedimientos estéticos, complicaciones cosméticas y calidad de vida. El grado de desarrollo de los temas depende esencialmente de las intervenciones estéticas. El análisis de correspondencia múltiple basado en las palabras clave de los autores reveló que el seguimiento de pacientes, el estudio de cohortes, la evaluación de riesgos, la evaluación de resultados, el rejuvenecimiento y los adultos son los elementos que complementan principalmente los subtemas de base. Conclusiones: Se ha identificado un crecimiento lento con una producción e impacto bajos en los últimos 20 años de investigación latinoamericana sobre el uso de la toxina botulínica en cirugía plástica. La investigación se ha centrado en estudios clínicos relacionados con la evaluación de resultados clínicos, calidad de vida y técnicas estéticas. Brasil lidera la investigación en la región y mantiene una fuerte red de colaboración intercontinental.
- Open Access
- 9 October 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 71, 102932
Practical guide for the use of medical evidence in scientific publication: Recommendations for the medical student: Narrative review
Currently, the adaptation of scientific evidence in clinical problem solving is based on the evidence-based medicine method. Medical students and health professionals should have an adequate knowledge of this method and thus provide adequate health care and increasingly provide high quality scientific publications that can be subsequently integrated in different clinical scenarios. Several scales and tools have been proposed as guides to recognize the different levels of quality of the available evidence, their degrees of recommendation and the biases and fallacies that may occur both in the clinical and research areas, with the aim of identifying the best available evidence. However, few students and professionals are aware of them and make proper use of them. Therefore, it is necessary to synthesize these tools in an understandable and practical way.
- 9 October 2021
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 71, 102932
Open AccessPractical guide for the use of medical evidence in scientific publication: Recommendations for the medical student: Narrative review
Currently, the adaptation of scientific evidence in clinical problem solving is based on the evidence-based medicine method. Medical students and health professionals should have an adequate knowledge of this method and thus provide adequate health care and increasingly provide high quality scientific publications that can be subsequently integrated in different clinical scenarios. Several scales and tools have been proposed as guides to recognize the different levels of quality of the available evidence, their degrees of recommendation and the biases and fallacies that may occur both in the clinical and research areas, with the aim of identifying the best available evidence. However, few students and professionals are aware of them and make proper use of them. Therefore, it is necessary to synthesize these tools in an understandable and practical way.